starting doses of Wegovy and Zepbound would cost Medicaid programs $350/month Duration : five-year model, concluding December 2031 Lifestyle support : all enrollees receiving GLP-1s for weight management must receive access to a lifestyle support program provided by the manufacturer at no cost Prior authorization : still required
Research published in Expert Opinion on Biological Therapy describes it as a "multi-functional regenerative peptide" with applications in corneal healing, cardiac repair, and general tissue regeneration
Tang ST, Tang HQ, Su H, Wang Y, Zhou Q, Zhang Q, Wang Y, Zhu HQ
Despite reasonably successful progress in clinical trials of its most advanced oral candidate danuglipron, the company halted development in April, owing to a possible drug-induced liver injury in one participant of an earlier study
2021;106(2):E592-601
PMC 9810348